Elaine Morlock, PhD

Position title: Medical Science Liaison, Sage Therapeutics

Phone: Advisor: Dr. Cynthia Czajkowski

Address:
Graduation: 06/2012

Alumni News

January 2017: Patent Agent at Klarquist

September 2012: Elaine became a patent technology specialist. Job Duty: writing patent applications for a small intellectual property law firm in Portland, OR.

Specializations

Certificated Emergency Medical Technician

Awards & Honors

Molecular and Cellular Pharmacology Program Travel Award. Full funding to attend and present at American Society for Pharmacology and Experimental Therapeutics annual meeting (April 2012)
Best Molecular and Cellular Pharmacology Seminar (2011)
Vilas Travel Award (2011)
Ruth L. Kirschstein National Research Service Award NIH Predoctoral Fellowship. 2010-2012.

Skills: Western Blotting and Molecular Biology

Publications

Andrew AS, Hu T, Gu J, Gui J, Ye Y, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Mason RA, Morlock EV, Zens MS, Li Z, Moore JH, Wu X, and Karagas MR (2012). HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer. PLoS One. 7:e51301. Epub 2012 Dec 19. PMCID: PMC3526593
Morlock EV and Czajkowski C (2011). Different residues in the GABAA receptor benzodiazepine binding pocket mediate benzodiazepine efficacy and binding.Mol Pharmacol. 80:14-22. PMCID: PMC3127544
Mason RA, Morlock EV, Karagas MR, Kelsey KT, Marsit CJ, Schned AR, and Andrew AS (2009). EGFR Pathway Polymorphisms and Bladder Cancer Susceptibility and Prognosis. Carcinogenesis. 30:1155-1160. PMCID: PMC2704279
Andrew AS, Kelsey KT, Gui J, Morlock EV, Mason RA, Moore JH, and Karagas MR. (2009) Bladder cancer SNP panel predicts susceptibility and survival. Hum. Genet. 125:527-539. PMCID: PMC2763504
Hanson SM, Morlock EV, Satyshur KA, Czajkowski C (2008). Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different. J Med Chem. 51:7243-52. PMCID: PMC2645942